Literature DB >> 32488461

An EPR Study Using Cyclic Hydroxylamines To Assess The Level of Mitochondrial ROS in Superinvasive Cancer Cells.

Samantha Scheinok1, Tania Capeloa2, Paolo E Porporato3, Pierre Sonveaux2, Bernard Gallez4.   

Abstract

It has been proposed that a mitochondrial switch involving a high mitochondrial superoxide production is associated with cancer metastasis. We here report an EPR analysis of ROS production using cyclic hydroxylamines in superinvasive SiHa-F3 compared with less invasive SiHa wild-type human cervix cancer cells. Using the CMH probe, no significant difference was observed in the overall level of ROS between SiHa and SiHa-F3 cells. However, using mitochondria-targeted cyclic hydroxylamine probe mitoTEMPO-H, we detected a significantly higher mitochondrial ROS content in SiHa-F3 compared with the wild-type SiHa cells. To investigate the nature of mitochondrial ROS, we overexpressed superoxide dismutase 2, a SOD isoform exclusively localized in mitochondria, in SiHa-F3 superinvasive cells. A significantly lower signal was detected in SiHa-F3 cells overexpressing SOD2 compared with SiHa-F3. Despite some limitations discussed in the paper, our EPR results suggest that mitochondrial ROS (at least partly superoxide) are produced to a larger extent in superinvasive cancer cells compared with less invasive wild-type cancer cells.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32488461     DOI: 10.1007/s12013-020-00921-6

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  3 in total

1.  Measurement of Mitochondrial (Dys)Function in Cellular Systems Using Electron Paramagnetic Resonance (EPR): Oxygen Consumption Rate and Superoxide Production.

Authors:  Donatienne d'Hose; Bernard Gallez
Journal:  Methods Mol Biol       Date:  2022

2.  Inhibition of Mitochondrial Redox Signaling with MitoQ Prevents Metastasis of Human Pancreatic Cancer in Mice.

Authors:  Tania Capeloa; Justine A Van de Velde; Donatienne d'Hose; Sara G Lipari; Françoise Derouane; Loïc Hamelin; Marie Bedin; Thibaut Vazeille; François P Duhoux; Michael P Murphy; Paolo E Porporato; Bernard Gallez; Pierre Sonveaux
Journal:  Cancers (Basel)       Date:  2022-10-07       Impact factor: 6.575

3.  MitoQ Inhibits Human Breast Cancer Cell Migration, Invasion and Clonogenicity.

Authors:  Tania Capeloa; Joanna Krzystyniak; Donatienne d'Hose; Amanda Canas Rodriguez; Valery L Payen; Luca X Zampieri; Justine A Van de Velde; Zohra Benyahia; Erica Pranzini; Thibaut Vazeille; Maude Fransolet; Caroline Bouzin; Davide Brusa; Carine Michiels; Bernard Gallez; Michael P Murphy; Paolo E Porporato; Pierre Sonveaux
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.